跳至主要内容
临床试验/ACTRN12613000273785
ACTRN12613000273785尚未招募不适用

The effect of beta-alanine supplementation on exercise capacity in individuals with type 2 diabetes: a randomized double-blind, placebo-controlled trial

Southern Cross University0 个研究点目标入组 40 人开始时间: 2013年3月6日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Male

入选标准

  • Diagnosis of type 2 diabetes.
  • Medically stable and medically managed.
  • No documented cardiac history or stable cardiac history for previous 6 months.
  • No change in diabetes medications for previous two months.
  • Not currently taking exogenous insulin injections.
  • Signed consent from their general practitioner (GP) or specialist.

排除标准

  • Diabetic complications which may be worsened by exercise.
  • Change in medications during previous 2 months.
  • Unstable cardiovascular disease, stroke, or other conditions which might be worsened by exercise.
  • Lower limb injuries or chronic limb impairment which may preclude completion of a treadmill protocol.

研究者

相似试验

Effect of beta-alanine supplementation on exercise... | 临床试验